Toro Company vice president Amy Dahl to depart at end of September
Investing.com -- GE Healthcare (NASDAQ:GEHC) is working with advisers to explore strategic options for its China operations, including a potential sale of the unit, Reuters reported on Friday, citing a source familiar with the matter.
The U.S. medical device manufacturer is considering multiple scenarios for its China business, which could involve selling the entire unit, finding a Chinese partner, or divesting a partial stake, the report said.
While discussions are still in early stages, the China unit would likely be valued in the billions of dollars, though a precise valuation is difficult to determine at this point, it added.
GE Healthcare’s strategic review comes as many multinational companies reassess their operations in China amid changing market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.